Clinical Trials in Pittsburgh

Showing 18821-18840 of 21,047 trials

Maintenance Interpersonal Psychotherapy for Sustaining Remission of Depression

NCT00227981

This study will evaluate the effectiveness of maintenance interpersonal psychotherapy (IPT) in preventing relapse of depression in women who have required combined psychotherapy and pharmacotherapy treatment to obtain a remission of depression symptoms.

Depression

University of Pittsburgh93 participantsStarted Mar 1995

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 4< 1 mile

Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder

NCT00178061

This study will examine the impact of comorbid personality disorder on the outcome of treatment among patients with bipolar I disorder.

Bipolar I DisorderBorderline Personality Disorder

University of Pittsburgh13 participantsStarted Aug 1997

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

NCT00006786

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Bevacizumab may stop the growth of colorectal cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus bevacizumab in treating patients who have advanced colorectal cancer.

Colorectal Cancer

Eastern Cooperative Oncology GroupStarted Nov 2000

Scottsdale, Arizona, United States • Duarte, California, United States • Palo Alto, California, United States +74 more locations

Maintenance Interpersonal Psychotherapy for Sustaining Remission of Depression

Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Find Trials by Condition in Pittsburgh

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

National Inferior Vena Cava (IVC) Filter Registry

Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Irinotecan in Treating Patients With Recurrent Malignant Glioma

Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione